Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Ustekinumab”

201 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 201 results

Not applicableLooking for participantsNCT05387031
What this trial is testing

Efficacy of Ustekinumab Therapy in Patients With Symptomatic Stricturing Crohn's Disease

Who this might be right for
Crohn DiseaseStricture; BowelIntestinal Stricture
Second Affiliated Hospital, Zhejiang University, School of Medicine 239
Post-approval studies (Phase 4)Study completedNCT05029921
What this trial is testing

Ustekinumab (STELARA) in Chinese Participants With Moderately to Severely Active Crohn's Disease

Who this might be right for
Crohn Disease
Janssen Research & Development, LLC 182
Post-approval studies (Phase 4)UnknownNCT02693470
What this trial is testing

The Difference of Microparticles in Patients With Psoriasis Vulgaris Who Received Stelara(Ustekinumab)

Who this might be right for
Psoriasis With Cell-derived Microparticles
Chang Gung Memorial Hospital 100
Large-scale testing (Phase 3)Study completedNCT02698475
What this trial is testing

An Efficacy, Safety, and Pharmacokinetics Study of Subcutaneously Administered Ustekinumab in the Treatment of Moderate to Severe Chronic Plaque Psoriasis in Pediatric Participants Greater Than or Equal to 6 to Less Than 12 Years of Age

Who this might be right for
Psoriasis
Janssen Research & Development, LLC 44
Large-scale testing (Phase 3)Study completedNCT00747344
What this trial is testing

Trial to Look at the Safety and Effectiveness of Ustekinumab in Korean and Taiwanese Subjects With Moderate to Severe Plaque-type Psoriasis

Who this might be right for
Psoriasis
Centocor, Inc. 121
Not applicableStudy completedNCT07100093
What this trial is testing

Prospective, Multicenter Study on the Association Between Serum Ustekinumab Levels and Clinical, Biological and Endoscopic Remission in Patients With Crohn's Disease.

Who this might be right for
Ustekinumab Serum Levels in Patients With Crohn´s Disease
Hospital Universitario La Paz 100
Not applicableUnknownNCT05057832
What this trial is testing

Determination of Ustekinumab Levels in Patients With Crohn's Disease

Who this might be right for
Crohn Disease
Fundación Pública Andaluza para la gestión de la Investigación en Sevilla 95
Post-approval studies (Phase 4)Study completedNCT01511315
What this trial is testing

The Quality of Life Study in Psoriasis Patients After Ustekinumab Treatment

Who this might be right for
Psoriasis
University of California, San Francisco 36
Not applicableStudy completedNCT02627768
What this trial is testing

A Study on Assessment of STELARA and Tumor Necrosis Factor Alpha Inhibitor Therapies in Participants With Psoriatic Arthritis

Who this might be right for
Psoriatic Arthritis
Janssen Pharmaceutica N.V., Belgium 991
Early research (Phase 1)Study completedNCT01276847
What this trial is testing

Assess the Effect of Ustekinumab (Stelara®) and Etanercept (Enbrel®) in Participants With Moderate to Severe Psoriasis (MK-0000-206)

Who this might be right for
Psoriasis
Merck Sharp & Dohme LLC 40
Large-scale testing (Phase 3)Ended earlyNCT03981744
What this trial is testing

Ustekinumab in Participants With Active Polymyositis and Dermatomyositis Who Have Not Adequately Responded to One or More Standard-of-care Treatments

Who this might be right for
PolymyositisDermatomyositis
Janssen Pharmaceutical K.K. 51
Testing effectiveness (Phase 2)Ended earlyNCT02955147
What this trial is testing

Ustekinumab for the Treatment of Giant Cell Arteritis

Who this might be right for
Giant Cell ArteritisTemporal ArteritisHorton's Disease
Massachusetts General Hospital 13
Testing effectiveness (Phase 2)Study completedNCT03711448
What this trial is testing

Ustekinumab for the Treatment of Relapse of Refractory Giant Cell Arteritis

Who this might be right for
Patients Relapsing Refractory Giant Cell Arteritis
Centre Hospitalier Universitaire Dijon 38
Large-scale testing (Phase 3)Study completedNCT01009086
What this trial is testing

The Safety and Effectiveness of Ustekinumab in Patients With Psoriatic Arthritis

Who this might be right for
Arthritis, Psoriatic
Janssen Research & Development, LLC 615
Not applicableLooking for participantsNCT07746583
What this trial is testing

Guselkumab Given After Ustekinumab in Participants With Moderate to Severe Psoriasis in Routine Clinical Practice

Who this might be right for
Psoriasis
Janssen-Cilag Kft. 100
Testing effectiveness (Phase 2)Study completedNCT03366142
What this trial is testing

Ustekinumab (Anti-IL-12/23p40 Monoclonal Antibody) in Patients With Leukocyte Adhesion Deficiency Type 1 (LAD1) Who Have Inflammatory Pathology

Who this might be right for
LAD1
National Institute of Allergy and Infectious Diseases (NIAID) 6
Large-scale testing (Phase 3)Study completedNCT00723528
What this trial is testing

An Efficacy and Safety Study of Ustekinumab (CNTO 1275) in Participants With Plaque Psoriasis

Who this might be right for
Psoriasis
Janssen Pharmaceutical K.K. 158
Not applicableStudy completedNCT03942120
What this trial is testing

Post-Marketing Surveillance for Crohn's Disease Participants Treated With Stelara (Ustekinumab)

Who this might be right for
Crohn Disease
Janssen Korea, Ltd., Korea 685
Large-scale testing (Phase 3)Study completedNCT01369329
What this trial is testing

Evaluate the Safety and Efficacy of Ustekinumab in Patients With Moderately to Severely Active Crohn's Disease Who Have Failed or Are Intolerant to Tumor Necrosis Factor (TNF) Antagonist Therapy (UNITI-1)

Who this might be right for
Crohn's DiseaseIBDColitis+1 more
Janssen Research & Development, LLC 769
Large-scale testing (Phase 3)Study completedNCT02074982
What this trial is testing

Efficacy of Secukinumab Compared to Ustekinumab in Patients With Plaque-type Psoriasis

Who this might be right for
Chronic Plaque Type Psoriasis
Novartis Pharmaceuticals 676
Next Page